Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6–35 months: A multi-center, randomized, double-blind, active-controlled clinical trial

Authors

Institutions

Publication Details

Journal
Vaccine
Published
2025-12-13
DOI
https://doi.org/10.1016/j.vaccine.2025.128113
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6–35 months: A multi-center, randomized, double-blind, active-controlled clinical trial

Siquan Wang, Chenyan Zhao, Jihai Tang, Wanqi Yang et al.
Vaccine
Influenza Virus Research Studies
article

Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6–35 months: A multi-center, randomized, double-blind, active-controlled clinical trial

Siquan Wang, Chenyan Zhao, Jihai Tang, Wanqi Yang, Lei Wang, Taotao Zhu, Jun Li, Dan Li, Ye Tian, Tao Li, Xinyi Yang, Zhao Jiang, Xingya Pang, Yeqing Tong, Lanshu Li
article en

Abstract

No abstract available for this paper.
VaccineVol. 71
Sinovac Biotech (CN), Hubei Provincial Center for Disease Control and Prevention (CN), Anhui Provincial Center for Disease Control and Prevention (CN), National Institutes for Food and Drug Control (CN)
Openalex Percentile: Top 48%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6–35 months: A multi-center, randomized, double-blind, active-controlled clinical trial — Siquan Wang, Chenyan Zhao, et al. · Vaccine (2025) | TGRS Research Map | TGRS